Longevity and anti-aging research
In February 2019, a group of 16 researchers from Harvard, MIT and other institutions around the USA and Europe launched the non-profit Academy for Health and Lifespan Research to promote future work, ease collaborations between scientist and ensure that governments and corporations are making desicions based on the latest scientific facts instead of rumor, speculation, or hype.
Professor David Sinclair at Harvard Medical School of Genetics, one of the new academy’s founding members, said in an interview with The Harvard Gazette about the status of aging research: “The 16 researchers in the academy have all been working on this for most, if not all, of our careers.”
Recently, we’ve moved from being able to extend health and lifespan of simple organisms to complex organisms such as mice and monkeys.
The reason we can extend the lifespan of animals is not that we can just make them live longer, but also keeping them healthy. The animals defer conditions such as heart disease, cancer, Alzheimer’s until up to as much as 20 percent later in their lifespan. That means 20 percent longer useful lifespan, not just 20 percent longer lifespan.
AndoSan and NAD-boosters
According to Professor Davis Sinclair’s research, the biggest potential for anti-aging is a group of substances known as NAD boosters. NAD is a coenzyme that is critical to metabolism and which is known to diminish with age. Current research shows that being able to boost the level of NAD may significantly reduce the effects of aging and increase lifespan through rejuvenation of cells.
The best documented NAD-booster is currently in the novel food stage at EFSA. ImmunoPharma intends to be one of the very first companies to bring this valuable substance to the European market. By combining the cell rejuvenating effects of the NADbooster with the well-known immune-modulating effects of AndoSan, we will hit the market with a truly unique product.
Also, the typical customer of a longevity product will be in the 50+ age group. A lot of people in this age group are having great difficulties with digestion and the resultant reduction in uptake of vital nutrients. AndoSan has been shown to have very positive effects on people with conditions such as Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). It is therefore expected that the inclusion of AndoSan in the product will improve the uptake of the NAD-booster.
Market survey confirms the potential of a longevity product
An extensive market survey conducted by the market research company SurveyMonkey with the name: How long adults want to live, confirms the huge potential for a longevity product.
The study was done in North America, where the average expected life span for women is 81 and 77 years for men. 63% in the survey answered that they would like to live longer and the same percentage answered that they would like to live past the age of 100, with 51% on the condition how they are doing with regard to diseases such as Alzheimer’s, type-2 diabetes, cancer, and dementia . Some results from the survey are shown in the graphs.